Amgen Statistics and Revenue Totals for 2024

Amgen Inc. is a prominent biotechnology company headquartered in Thousand Oaks, California. Founded in 1980, Amgen has grown to become one of the largest biopharmaceutical companies in the world. The company’s primary focus is on the discovery, development, and manufacturing of innovative medicines, particularly in the fields of oncology, nephrology, rheumatology, and other serious medical conditions.
Amgen has made significant contributions to the biotechnology industry with the development of groundbreaking therapies, including drugs to treat cancer, bone diseases, and autoimmune disorders. One of their most well-known products is Epogen, used to treat anemia associated with chronic kidney disease and chemotherapy.

Amgen Statistics

Amgen Employee Count

Amgen number of employees:

24,200 staff members

Last updated 2/1/22

Amgen Revenue Totals

Amgen annual revenue:

• 2022: $26.323 billion
• 2021: $25.979 billion
• 2020: $25.424 billion
• 2019: $23.362 billion
• 2018: $23.747 billion
• 2017: $22.849 billion
• 2016: $22.991 billion
• 2015: $21.662 billion
• 2014: $20.063 billion
• 2013: $18.676 billion

Amgen annual net income:

• 2022: $6.552 billion
• 2021: $5.893 billion
• 2020: $7.264 billion
• 2019: $7.842 billion
• 2018: $8.394 billion
• 2017: $1.979 billion
• 2016: $7.222 billion
• 2015: $6.939 billion
• 2014: $5.158 billion
• 2013: $5.081 billion

Additional Amgen Statistics

Number of countries Amgen has a presence in:
100Last updated 9/12/18

Amgen product share of total sales:2019:

• Enbrel: 24%
• Neulasta: 14%
• Prolia: 12%
• XGEVA: 9%
• Aranesp: 8%
• KYPROLIS: 5%
• EPOGEN: 4%
• Other: 22%

2018:

• Enbrel: 22%
• Neulasta: 20%
• Prolia: 10%
• Aranesp: 8%
• XGEVA: 8%
• Senispar Mimpara: 8%
• EPOGEN: 5%
• Other: 19%

Please note that some of these numbers are easier to find than others. A few of these Amgen statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.

Related Categories:

Related Tags:

About Craig Smith

DMR Publisher. Director of Marketing by day and I run this little site at night. Other interests include Disney, Sports, 80's Nostalgia, LEGO, Star Wars and Tech Gadgets. Other site is DisneyNews.us.

View all posts by Craig Smith →